F
Front Range Biosciences
Agricultural science for cannabis and hemp
About Front Range Biosciences
Front Range Biosciences operates in the agricultural biotechnology sector, specializing in the breeding, propagation, and production of high-value crops such as hemp and coffee. The company collaborates with farmers and research institutions to trial various plant genetics, aiming to improve crop yields and quality. Their business model focuses on providing field-tested, reliable, and quality-sorted seeds and clean plants to farmers, ensuring successful and sustainable farming practices. Front Range Biosciences generates revenue by selling these premium seeds and plants, as well as offering nursery services and expertise in plant breeding and propagation. The company serves a diverse range of clients, including individual farmers, agricultural businesses, and research institutions, primarily in regions where high-value crops are cultivated. By combining progressive research and development with modern agricultural techniques, Front Range Biosciences aims to enhance the growing experience for farmers and contribute to a more sustainable agricultural industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Boulder, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 71.9/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Coffee, Biotechnology, Cannabis, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2020 | $30M | $120M | Key Investment Partners | — |
| SERIES BOther financing | Feb 2020 | $19M | $75M | Undisclosed | — |
Growth signals
Latest recorded traffic for Front Range Biosciences is 160 monthly website visits, down 61.9% over the last three months. Front Range Biosciences's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
CanopyBoulder
Sand Hill Angels
Salveo Capital
HBS Alumni Angels of Greater New York
New York Angels
On Grid Ventures LLC
Series A5 investors entered at this stage
WelCan Capital
Cornerstone Angels- AMAltitude Investment Management
Militello Capital
Key Investment Partners
Series B and later3 investors entered at this stage
Anthill Ventures
HALLEY Venture Partners
Phyto Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Front Range Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Front Range Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.